Food and Drug Administration's Gastrointestinal Drugs Advisory Committee. September 15-16, 1988. The ACG Committee on FDA-related matters. American College of Gastroenterology

Am J Gastroenterol. 1989 Apr;84(4):351-4.
No abstract available

MeSH terms

  • Alprostadil / adverse effects
  • Alprostadil / analogs & derivatives*
  • Alprostadil / pharmacokinetics
  • Alprostadil / pharmacology
  • Alprostadil / therapeutic use
  • Aminosalicylic Acids / adverse effects
  • Aminosalicylic Acids / pharmacokinetics
  • Aminosalicylic Acids / therapeutic use*
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / prevention & control
  • Drug Evaluation
  • Humans
  • Misoprostol
  • Stomach Ulcer / chemically induced
  • Stomach Ulcer / prevention & control*
  • United States
  • United States Food and Drug Administration*

Substances

  • Aminosalicylic Acids
  • Anti-Inflammatory Agents, Non-Steroidal
  • Misoprostol
  • Alprostadil
  • olsalazine